Search results
AstraZeneca's COVID-19 Prevention Drug For Patients With Weak Immune Systems - European Medicines...
Benzinga via Yahoo Singapore Finance· 5 days agoAstraZeneca's application for sipavibart has been accepted under an accelerated assessment...
Regeneron (REGN) Gets Positive CHMP Opinion for Lymphoma Drug
Zacks via Yahoo Singapore Finance· 5 days agoRegeneron (REGN) gets positive CHMP recommendation for odronextamab for the treatment of adults with...
AbbVie (ABBV) Gets CHMP Nod for Lymphoma Drug's Expanded Use
Zacks via Yahoo Singapore Finance· 5 days agoAbbVie (ABBV) is seeking approval for Tepkinly in the EU as a monotherapy for the treatment of adult...
Eli Lilly (LLY) Gets FDA Nod for Alzheimer's Drug Donanemab
Zacks via Yahoo Singapore Finance· 3 days agoEli Lilly's (LLY) Alzheimer's disease drug, Kisunla (donanemab), wins FDA approval. Kisunla will be...
Roche (RHHBY) Gets Positive CHMP Recommendation for Its Drugs
Zacks via Yahoo Singapore Finance· 5 days agoRoche (RHHBY) gets CHMP recommendation for a label expansion of ophthalmology drug Vabysmo...
AstraZeneca (AZN) Imfinzi Combo Gets CHMP Nod for Expanded Use
Zacks via Yahoo Singapore Finance· 4 days agoThe CHMP recommends approval of AstraZeneca's (AZN) Imfinzi plus Lynparza for treating primary...
Is Royalty Pharma plc (RPRX) a Good Stock to Buy Now?
Insider Monkey via Yahoo Singapore Finance· 3 days agoWe recently compiled a list of the 10 Best Undervalued Stocks To Buy Now. In this article, we are...
C4 Therapeutics, Inc. (CCCC): Is This the Best Biotech Penny Stock to Buy Now?
Insider Monkey via Yahoo Singapore Finance· 6 days agoWe recently compiled a list of the 10 Best Biotech Penny Stocks to Buy Now. In this article, we are...
Merck (MRK) Gets Exclusive Rights to Opevesostat From Partner
Zacks via Yahoo Singapore Finance· 4 days agoMerck (MRK) exercises the option that will convert the collaboration deal with partner Orion for...
Should You Expect Upside Potential For Pfizer (PFE)?
Insider Monkey via Yahoo Singapore Finance· 5 days agoParnassus Investments, an investment management company, released the “Parnassus Value Equity Fund” first quarter 2024 investor letter. A copy of the...